
Blog
How corruption affects the quality and integrity of medical products and impacts on the Covid-19 response
13th December 2021
Access to quality medicines and medical products is considered to be one of the fundamental elements for realising the human right to health.
The World Health Organization (WHO), however, estimates that one in every ten medical products in low- and middle-income countries (LMICs) is substandard or falsified. This has only intensified under COVID-19, with opportunities for corruption rife as demand for PPE and vital medicines skyrocket.
Crown Agents’ Head of Procurement Delivery, Sarah Goldsmith, comments in U4 on the challenges of procuring medical products during the pandemic, and the lessons that need to be learnt to protect health system supply chains for future emergencies.
Sector
Capability
Related
Sustainable Public Procurement
Climate & Energy / Governance and Public Administration / Procurement / Supply Chain / Climate and Energy / Institutional Efficiency / Procurement / Programme Design, Delivery and Evaluation
Sustainable Public Procurement
Climate & Energy / Governance and Public Administration / Procurement / Supply Chain / Climate and Energy / Institutional Efficiency / Procurement / Programme Design, Delivery and Evaluation
Ukraine 2021: Program 5 Medical products for patients with epidermolysis bullosa / Програма 5 – Медичні вироби для громадян, які страждають на бульозний епідермоліз
Health / Procurement / Supply Chain / Procurement / Supply Chain
Ukraine 2021: Program 5 Medical products for patients with epidermolysis bullosa / Програма 5 – Медичні вироби для громадян, які страждають на бульозний епідермоліз
Health / Procurement / Supply Chain / Procurement / Supply Chain
Procurement Agent Services for Lesotho Millennium Development Agency (“LMDA”)
Economic Growth / Procurement / Procurement
Procurement Agent Services for Lesotho Millennium Development Agency (“LMDA”)
Economic Growth / Procurement / Procurement